FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/06/069287 [Registered on: 20/06/2024] Trial Registered Prospectively
Last Modified On: 19/06/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Other 
Public Title of Study   Correlation Between Serum Parathyroid Hormone and Alkaline Phosphatase in Chronic Kidney Disease Patients: A Study from Central India 
Scientific Title of Study   Correlation Of Serum Intact Parathyroid Hormone and Serum Alkaline Phosphatase Amongst the Patients of Chronic Kidney Disease in A Rural Tertiary Care Hospital in Central India  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Soumya Malde 
Designation  Senior Resident  
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Datta Meghe Institute of Higher Education and Research
Datta Meghe Institute of Higher Education and Research
Wardha
MAHARASHTRA
442001
India 
Phone  8983366987  
Fax    
Email  Sunnymalde94@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Soumya Malde 
Designation  Senior Resident  
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Datta Meghe Institute of Higher Education and Research
Datta Meghe Institute of Higher Education and Research

MAHARASHTRA
442001
India 
Phone  8983366987  
Fax    
Email  Sunnymalde94@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Manish Balwani 
Designation  Professor 
Affiliation  Datta Meghe Institute of Higher Education and Research 
Address  Datta Meghe Institute of Higher Education and Research
Datta Meghe Institute of Higher Education and Research
Wardha
MAHARASHTRA
442001
India 
Phone  8983366987  
Fax    
Email  balwani.manish@yahoo.com  
 
Source of Monetary or Material Support  
Datta Meghe Institute of Medical Sciences Sawangi (Meghe) Wardha  
 
Primary Sponsor  
Name  None 
Address  Nil 
Type of Sponsor  Other [Nil] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Sunny Malde  Acharya Vinoba Bhave Rural Hospital, Sawangi (Meghe) Wardha  Acharya Vinoba Bhave Rural Hospital, Sawangi (Meghe) Wardha
Wardha
MAHARASHTRA 
8983366987

Sunnymalde94@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Datta Meghe Institute of Medical Sciences Sawangi (Meghe) Wardha  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: I00-I99||Diseases of the circulatory system,  
 
Intervention / Comparator Agent  
Type  Name  Details 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  18.00 Year(s)
Gender  Both 
Details  This is a single-center observational prospective study conducted at the AVBRH hospital under the Department of Nephrology. All patients on regular follow-up and on maintenance haemodialysis treatment from Acharya Vinoba Bhave Rural Hospital were eligible for participation, subject to the inclusion and exclusion criteria. 
 
ExclusionCriteria 
Details  Age more than 18 years diagnosed to have Chronic kidney disease Stage IV, V and patient on Dialysis 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
The primary outcome of this study is to determine the correlation between serum intact parathyroid hormone (iPTH) and serum alkaline phosphatase (ALP) levels among patients with Chronic Kidney Disease (CKD) in a rural tertiary care hospital in Central India  All parameters will be assessed at the baseline at the time of enrollment. 
 
Secondary Outcome  
Outcome  TimePoints 

In addition to the primary outcome of correlating serum intact parathyroid hormone (iPTH) and serum alkaline phosphatase (ALP) levels in Chronic Kidney Disease (CKD) patients, this study aims to determine the prevalence of mineral and bone disorder (MBD) in CKD patients, analyze disease burden across CKD stages, explore factors influencing iPTH and ALP levels, evaluate their relationship with other biochemical markers and clinical parameters, identify predictors of adverse outcomes, assess intervention impacts on iPTH and ALP levels, and compare iPTH and ALP levels between dialysis and non-dialysis CKD patients.
 
1 Month 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   01/08/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="2"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   a study conducted in a rural tertiary care hospital in Central India aiming to investigate the correlation between serum intact parathyroid hormone (iPTH) and serum alkaline phosphatase (ALP) levels among patients with Chronic Kidney Disease (CKD). The rationale behind the study is to assess cost-effective investigations for diagnosing CKD mineral and bone disorder (MBD) and potentially improving patient outcomes. The study design is a cross-sectional study with a duration of 24 months, conducted at Acharya Vinoba Bhave Rural Hospital. The sample size is determined to be 120 patients meeting specific inclusion criteria. Data collection involves obtaining baseline demographic and clinical data, including age, gender, BMI, and blood pressure, and analyzing serum samples for various biochemical markers. Ethical considerations, including patient confidentiality and informed consent, are emphasized. The primary outcome is the correlation between iPTH and ALP levels, while secondary outcomes include assessing MBD prevalence, disease burden across CKD stages, and exploring factors associated with elevated iPTH and ALP levels. The abstract highlights the study’s potential contributions to CKD management in the rural Indian population. 
Close